Skip to main content
SpringerLink
Log in

Vena Cava Interruption

  • Chapter
  • First Online:
Current Management of Venous Diseases

  • 1937 Accesses

Abstract

Despite aggressive prevention and treatment of venous thromboembolic disease, the numbers of patients that suffer from pulmonary embolism annually are greater in number than the population of the state of Alaska. With our aging population, the frequency of PE may even increase over time. When used for the correct indications, inferior vena cava filters are lifesaving and safe devices. Recent advancements in inferior vena cava filter design, specifically the development of retrievable IVC filters, have broadened the indications for filter placement and resulted in a marked increase in utilization. Recent recognition of IVC filter complications associated primarily with these new devices has led to increase scrutiny of IVC filters and IVC filter use resulting in FDA alert letters and increasing litigation associated with IVC filters. Current trials, such as the PRESERVE trial, are underway to better understand the real-world use of IVC filters and their rates of complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Kearon C, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th edition. Chest. 2012;141(2 suppl):419–963.

    Article  Google Scholar 

  2. Jaff MR, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–830.

    Article  PubMed  Google Scholar 

  3. Hirsh J. Oral anticoagulant drugs. N Engl J Med. 1991;324(26):1865–75.

    Article  CAS  PubMed  Google Scholar 

  4. Harrington R, et al. Risk-benefit assessment of anticoagulant therapy.1. Drug Saf. 1991;6(1):54–69.

    Article  CAS  PubMed  Google Scholar 

  5. Schmitt BP, Adelman B. Heparin-associated thrombocytopenia: a critical review and pooled analysis. Am J Med Sci. 1993;305(4):208–15.

    Article  CAS  PubMed  Google Scholar 

  6. Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993;93(30):315–28.

    Article  Google Scholar 

  7. Eby CS. Warfarin-induced skin necrosis. Hematol Oncol Clin North Am. 1993;7(6):1291–300.

    CAS  PubMed  Google Scholar 

  8. Hull RD, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med. 1992;152(8):1589–95.

    Article  CAS  PubMed  Google Scholar 

  9. Hull RD, et al. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence. Arch Intern Med. 1997;157(20):2317–21.

    Article  CAS  PubMed  Google Scholar 

  10. Kasarina S, et al. Prophylactic greenfield filter placement in selected high-risk trauma patients. J Vasc Surg. 1995;22(3):231–5.

    Article  Google Scholar 

  11. Shackford SR, et al. Venous thromboembolism in patients with major trauma. Am J Surg. 1990;159(4):365–9.

    Article  CAS  PubMed  Google Scholar 

  12. Rogers FB, et al. Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients. Arch Surg. 1998;133(4):406–11.

    Article  CAS  PubMed  Google Scholar 

  13. McMurtry AL, et al. Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism. J Am Coll Surg. 1999;189(3):314–20.

    Article  CAS  PubMed  Google Scholar 

  14. Rowland SP, et al. Inferior vena cava filters for prevention of venous thromboembolism in obese patients undergoing bariatric surgery: a systematic review. Ann Surg. 2015;261(1):35–45.

    Article  PubMed  Google Scholar 

  15. McClendon J, et al. Comprehensive assessment of prophylactic preoperative inferior vena cava filters for major spinal reconstruction in adults. Spine. 2012;37(13):1122–9.

    Article  PubMed  Google Scholar 

  16. Ozturk C, et al. Efficacy of prophylactic placement of inferior vena cava filters in patients undergoing spinal surgery. Spine. 2010;35(20):1893–6.

    Article  PubMed  Google Scholar 

  17. Falanga A, Donati MB. Pathogenesis of thrombosis in patients with malignancy. Int J Hematol. 2001;73(2):137–44.

    Article  CAS  PubMed  Google Scholar 

  18. Lin J, et al. Factors associated with recurrent venous thromboembolism in patients with malignant disease. J Vasc Surg. 2003;37(5):976–83.

    Article  PubMed  Google Scholar 

  19. Ihnat DM, et al. Treatment of patients with venous thromboembolism and malignant disease: should vena cava filters be routine? J Vasc Surg. 1998;28(5):800–7.

    Article  CAS  PubMed  Google Scholar 

  20. Gitter MJ, et al. Bleeding and thromboembolism during anticoagulation therapy: a population-based study in Rochester, Minnesota. Mayo Clin Proc. 1995;70:725–33.

    Article  CAS  PubMed  Google Scholar 

  21. Prandoni P, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulation in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484–8.

    Article  CAS  PubMed  Google Scholar 

  22. Krauth D, et al. Safety and efficacy of long-term oral anticoagulation in cancer patients. Cancer. 1987;59(5):983–5.

    Article  CAS  PubMed  Google Scholar 

  23. Laporte S, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the RIETE registry. Circulation. 2008;117(13):1711–6.

    Article  PubMed  Google Scholar 

  24. Somarouthu B, et al. Long-term safety and effectiveness of inferior vena cava filters in patients with stroke. J Neurointerv Surg. 2011;3(2):141–6.

    Article  PubMed  Google Scholar 

  25. Monsour M, et al. Interruption of the inferior vena cava for the preventions of recurrent pulmonary embolism. Am Surg. 1985;51(7):375–80.

    Google Scholar 

  26. Greenfield LJ, et al. Suprarenal filter placement. J Vasc Surg. 1988;28(3):432–8.

    Article  Google Scholar 

  27. Jacobs D, et al. Bedside vena cava filter placement with intravascular ultrasound: a simple, accurate, single venous access method. J Vasc Surg. 2007;46(6):1284–6.

    Article  PubMed  Google Scholar 

  28. Kalva S, et al. Suprarenal inferior vena cava filters: a 20-year single-center experience. J Vasc Interv Radiol. 2008;19(7):1041–7.

    Article  PubMed  Google Scholar 

  29. Decousus H, et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du risque d’embolie Pulmonaire par interruption cave study group. N Engl J Med. 1998;388(7):409–15.

    Article  Google Scholar 

  30. PREPIC Study Group. Eight-year follow up of patients with permanent vena cava filters in the preventions of pulmonary embolism: the PREPIC randomized study. Circulation. 2005;112(3):416–22.

    Article  Google Scholar 

  31. Mismetti P, et al. Effect of retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015;313(16):1627–35.

    Article  PubMed  Google Scholar 

  32. Morales P, et al. Decision analysis of retrievable inferior vena cava filters in patients without pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2013;1(4):376–84.

    Article  PubMed  Google Scholar 

  33. Ballew KA, et al. Vena cava filter devices. Clin Chest Med. 1995;16(2):295–305.

    CAS  PubMed  Google Scholar 

  34. Durack JC, et al. Perforation of the IVC: rule rather than exception after longer indwelling times for the Gunther Tulip and Celect retrievable filters. Cardiovasc Intervent Radiol. 2012;35(2):299–308.

    Article  PubMed  Google Scholar 

  35. Andreoli JM, et al. Comparison of complication rates associated with permanent and retrievable inferior vena cava filters: a review of the MAUDE database. J Vasc Interv Radiol. 2014;25(8):1181–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Vascular and Endovascular Surgery, Department of Surgery, University of Texas Southwestern Medical Center, 5959 Harry Hines Blvd, Dallas, TX, 75390-9157, USA

    John E. Rectenwald MD, MS

Authors
  1. John E. Rectenwald MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John E. Rectenwald MD, MS .

Editor information

Editors and Affiliations

  1. Section of Vascular Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA

    Cassius Iyad Ochoa Chaar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rectenwald, J.E. (2018). Vena Cava Interruption. In: Chaar, C. (eds) Current Management of Venous Diseases . Springer, Cham. https://doi.org/10.1007/978-3-319-65226-9_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65226-9_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65225-2

  • Online ISBN: 978-3-319-65226-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation